Sexual
Kisspeptin
Hormonal
9
Amino acids
Molecular weight
Peptide
Type
Kisspeptin acts as a master regulator of the reproductive system, stimulating GnRH neurons essential for puberty, fertility, and reproductive function.
Binds to GPR54/KISS1R receptors on hypothalamic GnRH neurons, triggering pulsatile GnRH release, which stimulates pituitary LH/FSH secretion and gonadal steroid production.
Lyophilized: Room temperature. Reconstituted: 2-8°C. KP-10: use within 7 days. KP-54: use within 14 days
Single dose for testing, or 2-3 times weekly (NEVER daily - causes desensitization)
100-200 mcg per injection
2-4 weeks
Potent reproductive hormone stimulation (LH/FSH)
Restoration of natural testosterone production
Fertility enhancement
Sexual function support
Hypogonadism treatment potential
This peptide is still gaining traction in the community.
KISS1 Gene Product | Reproductive Neuropeptide
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Kisspeptin.
9
Amino Acids
Kisspeptin
Asn
Asn
Position 1
Trp
Trp
Position 2
Asn
Asn
Position 3
Ser
Ser
Position 4
Phe
Phe
Position 5
Gly
Gly
Position 6
Leu
Leu
Position 7
Arg
Arg
Position 8
Phe
Phe
Position 9
Standard administration route; allows precise dosing and rapid hormone stimulation.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Gonadotropin stimulation | 100 | 2 week range | SubQ |
| Fertility support | 0.4 | — | SubQ (KP-54) |
| Sexual function (clinical) | 1 | 75 week range | IV infusion |
Materials needed:
Steps to reconstitute
The Kisspeptin Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Kisspeptin
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Kisspeptin vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Kisspeptin interactions with other common peptides and substances.
Sexual
hcg
Hormonal
COMPATIBLE
Serves as potentially safer alternative for IVF ovulation triggering.
Not recommended during pregnancy or breastfeeding
Caution with cardiovascular disease history
Daily dosing causes receptor desensitization
Ovarian hyperstimulation signs: severe pelvic pain, bloating, nausea
Chest pain or cardiovascular symptoms
Severe headaches or visual disturbances
Persistent injection site reactions
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Kisspeptin is an emerging compound
Kisspeptin
Kisspeptin is an emerging compound
Kisspeptin for Hypoactive Sexual Desire Disorder in Men
Modulated sexual brain activity; increased penile tumescence by 56% vs placebo. JAMA Network Open.
2023
Kisspeptin for HSDD in Women
Modulated sexual and attraction processing; increased self-reported sexiness. JAMA Network Open.
2022
Kisspeptin as IVF Ovulation Trigger
45% live birth rate with zero severe OHSS; safer than hCG trigger. Journal of Clinical Investigation.
2017
Intranasal Kisspeptin Administration
Non-invasive delivery with rapid gonadotropin stimulation; stable 60-day formulation. eBioMedicine.
2025